CHEMED CORP (CHE) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CHE • US16359R1032

435.27 USD
+8.13 (+1.9%)
At close: Feb 2, 2026
435 USD
-0.27 (-0.06%)
Pre-Market: 2/3/2026, 5:39:30 AM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to CHE. CHE was compared to 102 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making CHE a very profitable company, without any liquidiy or solvency issues. CHE has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • CHE had positive earnings in the past year.
  • CHE had a positive operating cash flow in the past year.
  • Each year in the past 5 years CHE has been profitable.
  • In the past 5 years CHE always reported a positive cash flow from operatings.
CHE Yearly Net Income VS EBIT VS OCF VS FCFCHE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

  • CHE's Return On Assets of 17.17% is amongst the best of the industry. CHE outperforms 99.02% of its industry peers.
  • CHE's Return On Equity of 25.89% is amongst the best of the industry. CHE outperforms 92.16% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 21.27%, CHE belongs to the top of the industry, outperforming 96.08% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CHE is significantly above the industry average of 9.16%.
Industry RankSector Rank
ROA 17.17%
ROE 25.89%
ROIC 21.27%
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
CHE Yearly ROA, ROE, ROICCHE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • CHE has a Profit Margin of 11.02%. This is amongst the best in the industry. CHE outperforms 94.12% of its industry peers.
  • In the last couple of years the Profit Margin of CHE has grown nicely.
  • CHE has a better Operating Margin (14.60%) than 88.24% of its industry peers.
  • CHE's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 32.88%, CHE is in the better half of the industry, outperforming 63.73% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CHE has grown nicely.
Industry RankSector Rank
OM 14.6%
PM (TTM) 11.02%
GM 32.88%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
CHE Yearly Profit, Operating, Gross MarginsCHE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

9

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CHE is creating value.
  • Compared to 1 year ago, CHE has less shares outstanding
  • Compared to 5 years ago, CHE has less shares outstanding
  • CHE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CHE Yearly Shares OutstandingCHE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CHE Yearly Total Debt VS Total AssetsCHE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 11.64 indicates that CHE is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 11.64, CHE belongs to the top of the industry, outperforming 96.08% of the companies in the same industry.
  • The Debt to FCF ratio of CHE is 0.00, which is an excellent value as it means it would take CHE, only 0.00 years of fcf income to pay off all of its debts.
  • CHE has a better Debt to FCF ratio (0.00) than 94.12% of its industry peers.
  • CHE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • CHE has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. CHE outperforms 85.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.64
ROIC/WACC2.38
WACC8.92%
CHE Yearly LT Debt VS Equity VS FCFCHE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.35 indicates that CHE should not have too much problems paying its short term obligations.
  • CHE has a Current ratio (1.35) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.33 indicates that CHE should not have too much problems paying its short term obligations.
  • The Quick ratio of CHE (1.33) is comparable to the rest of the industry.
  • CHE does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.33
CHE Yearly Current Assets VS Current LiabilitesCHE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

  • CHE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.97%.
  • Measured over the past years, CHE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.64% on average per year.
  • Looking at the last year, CHE shows a small growth in Revenue. The Revenue has grown by 6.45% in the last year.
  • CHE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.63% yearly.
EPS 1Y (TTM)-3.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%-6.56%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%3.09%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.13% on average over the next years.
  • CHE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.17% yearly.
EPS Next Y-3.15%
EPS Next 2Y5.45%
EPS Next 3Y6.13%
EPS Next 5YN/A
Revenue Next Year5.02%
Revenue Next 2Y5.54%
Revenue Next 3Y5.17%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CHE Yearly Revenue VS EstimatesCHE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
CHE Yearly EPS VS EstimatesCHE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15 20 25

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 19.79, which indicates a rather expensive current valuation of CHE.
  • 70.59% of the companies in the same industry are more expensive than CHE, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 28.41. CHE is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 16.92, which indicates a correct valuation of CHE.
  • Based on the Price/Forward Earnings ratio, CHE is valued a bit cheaper than the industry average as 71.57% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 25.64. CHE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.79
Fwd PE 16.92
CHE Price Earnings VS Forward Price EarningsCHE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 62.75% of the companies in the same industry are more expensive than CHE, based on the Enterprise Value to EBITDA ratio.
  • CHE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CHE is cheaper than 70.59% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.1
EV/EBITDA 13.91
CHE Per share dataCHE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • CHE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.86
EPS Next 2Y5.45%
EPS Next 3Y6.13%

More info and screens

6

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.56%, CHE is not a good candidate for dividend investing.
  • CHE's Dividend Yield is rather good when compared to the industry average which is at 0.47. CHE pays more dividend than 81.37% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, CHE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.56%

5.2 History

  • The dividend of CHE is nicely growing with an annual growth rate of 8.02%!
  • CHE has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CHE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)8.02%
Div Incr Years16
Div Non Decr Years21
CHE Yearly Dividends per shareCHE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • CHE pays out 11.01% of its income as dividend. This is a sustainable payout ratio.
  • CHE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP11.01%
EPS Next 2Y5.45%
EPS Next 3Y6.13%
CHE Yearly Income VS Free CF VS DividendCHE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CHE Dividend Payout.CHE Dividend Payout, showing the Payout Ratio.CHE Dividend Payout.PayoutRetained Earnings

More info and screens

CHEMED CORP

NYSE:CHE (2/2/2026, 8:04:00 PM)

Premarket: 435 -0.27 (-0.06%)

435.27

+8.13 (+1.9%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-28
Earnings (Next)02-25
Inst Owners101.64%
Inst Owner Change-1.6%
Ins Owners1.52%
Ins Owner Change-7.07%
Market Cap6.16B
Revenue(TTM)2.53B
Net Income(TTM)278.81M
Analysts87.5
Price Target585.74 (34.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.56%
Yearly Dividend1.83
Dividend Growth(5Y)8.02%
DP11.01%
Div Incr Years16
Div Non Decr Years21
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.99%
Min EPS beat(2)-15.11%
Max EPS beat(2)-2.88%
EPS beat(4)1
Avg EPS beat(4)-4.45%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)2
Avg EPS beat(8)-3.19%
EPS beat(12)4
Avg EPS beat(12)-2.23%
EPS beat(16)8
Avg EPS beat(16)-1.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.85%
Min Revenue beat(2)-2.53%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-2.53%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.28%
Revenue beat(12)2
Avg Revenue beat(12)-1.05%
Revenue beat(16)2
Avg Revenue beat(16)-1.24%
PT rev (1m)0%
PT rev (3m)-0.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.58%
EPS NY rev (1m)0%
EPS NY rev (3m)0.18%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 19.79
Fwd PE 16.92
P/S 2.44
P/FCF 17.1
P/OCF 14.69
P/B 5.72
P/tB 18.98
EV/EBITDA 13.91
EPS(TTM)22
EY5.05%
EPS(NY)25.73
Fwd EY5.91%
FCF(TTM)25.46
FCFY5.85%
OCF(TTM)29.64
OCFY6.81%
SpS178.72
BVpS76.04
TBVpS22.94
PEG (NY)N/A
PEG (5Y)1.86
Graham Number194.01
Profitability
Industry RankSector Rank
ROA 17.17%
ROE 25.89%
ROCE 27.75%
ROIC 21.27%
ROICexc 23.56%
ROICexgc 62.89%
OM 14.6%
PM (TTM) 11.02%
GM 32.88%
FCFM 14.24%
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
ROICexc(3y)25.21%
ROICexc(5y)25.79%
ROICexgc(3y)67.33%
ROICexgc(5y)75.46%
ROCE(3y)28.73%
ROCE(5y)30.03%
ROICexgc growth 3Y-5.61%
ROICexgc growth 5Y0.34%
ROICexc growth 3Y-1.58%
ROICexc growth 5Y4.43%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
F-Score7
Asset Turnover1.56
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 92.02%
Cap/Sales 2.34%
Interest Coverage 250
Cash Conversion 96.74%
Profit Quality 129.28%
Current Ratio 1.35
Quick Ratio 1.33
Altman-Z 11.64
F-Score7
WACC8.92%
ROIC/WACC2.38
Cap/Depr(3y)89.59%
Cap/Depr(5y)94.39%
Cap/Sales(3y)2.41%
Cap/Sales(5y)2.56%
Profit Quality(3y)107.8%
Profit Quality(5y)110.23%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%-6.56%
EPS Next Y-3.15%
EPS Next 2Y5.45%
EPS Next 3Y6.13%
EPS Next 5YN/A
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%3.09%
Revenue Next Year5.02%
Revenue Next 2Y5.54%
Revenue Next 3Y5.17%
Revenue Next 5YN/A
EBIT growth 1Y-7.92%
EBIT growth 3Y4.05%
EBIT growth 5Y8.18%
EBIT Next Year14.67%
EBIT Next 3Y10.29%
EBIT Next 5YN/A
FCF growth 1Y39.38%
FCF growth 3Y13.77%
FCF growth 5Y8.19%
OCF growth 1Y30.35%
OCF growth 3Y10.6%
OCF growth 5Y6.75%

CHEMED CORP / CHE FAQ

What is the fundamental rating for CHE stock?

ChartMill assigns a fundamental rating of 7 / 10 to CHE.


What is the valuation status of CHEMED CORP (CHE) stock?

ChartMill assigns a valuation rating of 5 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.


Can you provide the profitability details for CHEMED CORP?

CHEMED CORP (CHE) has a profitability rating of 9 / 10.


Can you provide the financial health for CHE stock?

The financial health rating of CHEMED CORP (CHE) is 9 / 10.


What is the earnings growth outlook for CHEMED CORP?

The Earnings per Share (EPS) of CHEMED CORP (CHE) is expected to decline by -3.15% in the next year.